Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis

Overview of attention for article published in Frontiers in Molecular Neuroscience, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 73,359 followers.

RT @FrontNeurosci: New Research: Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis: Fingolimod…

28 Dec 2022

Reply Repost Favourite

New Research: Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis: Fingolimod is an oral immunomodulatory drug used in the treatment of multiple sclerosis (MS) that may change lipid… https://t.co/RUvpj54jEy #Molec

28 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.